Market Place
Sourcing Support
PolarityTE Secures $22.5M For SkinTE DFU Pivotal Phase 3
20 May 2024 //
GLOBENEWSWIRE
PolarityTE Announces First Subject Screened in Phase III Study Evaluating SkinTE
26 Feb 2024 //
GLOBENEWSWIRE
PolarityTE Confirms Receipt of Unsolicited Offer to Acquire the Company
09 Nov 2022 //
BIOSPACE
PolarityTE Reports Q2 2022 Rusult and Provides Business Update
11 Aug 2022 //
PRNEWSWIRE
PolarityTE Reports First Quarter 2022 Financial Results
16 May 2022 //
PRNEWSWIRE
PolarityTE Bags FDA RMAT Designation Granted to SkinTE
13 May 2022 //
PRNEWSWIRE
PolarityTE Submits Complete Response to FDA`s Clinical Hold for SkinTE IND
20 Dec 2021 //
PRNEWSWIRE
PolarityTE Provides Update on Investigational New Drug Application
07 Oct 2021 //
PRNEWSWIRE
PolarityTE makes CEO and CMO appointments
02 Sep 2021 //
SEEKING ALPHA
Manufacturing issues force PolarityTE to halt skin repair IND
24 Aug 2021 //
FIERCEPHARMA
PolarityTE stock tanks 19% on FDA clinical hold for SkinTE application
24 Aug 2021 //
BUSINESSWIRE
PolarityTE Reports Second Quarter Financial Results and Updates
12 Aug 2021 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.